Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Summit Therapeutics Inc. Director's Dealing 2021

Nov 16, 2021

30436_dirs_2021-11-16_68721825-71f6-40aa-b87e-cb67c26db2f0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Summit Therapeutics Inc. (SMMT)
CIK: 0001599298
Period of Report: 2021-11-03

Reporting Person: Gayko Urte (Director)

More from Summit Therapeutics Inc.

Interim / Quarterly Report 2026
Apr 30
Proxy Solicitation & Information Statement 2026
Apr 17
Annual Report 2026
Feb 23
Regulatory Filings 2026
Feb 23
Regulatory Filings 2026
Jan 29
Director's Dealing 2026
Jan 12
Regulatory Filings 2026
Jan 12
Director's Dealing 2026
Jan 7
Director's Dealing 2026
Jan 7
Director's Dealing 2026
Jan 7
View all filings →